DiscGenics is a development stage spinal therapeutics company using adult human disc-derived stem cells and tissue engineering techniques to treat patients debilitated by degenerative disc disease (DDD).  Back pain is the second most common reason to visit one’s doctor, and costs an estimated $100 billion in diagnosis, management, and lost productivity each year.  From our patented culture method comes the Discophere™, a therapeutic cluster of stem/progenitor cells that have been shown to differentiate and excrete the biological components needed to regenerate an intervertebral disc.

Click to accept cookies and enable this content

Contact DiscGenics
801-410-0703
anthony@discgenics.com
Visit Website